Hypoxia promotes stem cell-like phenotype in multiple myeloma cells

Blood Cancer Journal

Volumn 4, Issue 12, 2014, Pages e262-

  Muz, B ^a   De La Puente, P ^a   Azab, F ^a   Luderer, M ^a   Azab, A K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN E; PROTEASOME INHIBITOR; REACTIVE OXYGEN METABOLITE; SYNDECAN 1;

APOPTOSIS; CANCER STEM CELL; CELL DEDIFFERENTIATION; CELL PROLIFERATION; DNA SYNTHESIS; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HYPOXIC CELL; LETTER; MULTIPLE MYELOMA CELL LINE; PHENOTYPE; TUMOR RECURRENCE; CELL HYPOXIA; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; MULTIPLE MYELOMA; NEOPLASTIC STEM CELLS;

EID: 84927935971     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.82     Document Type: Letter

References (19)

1. de la Puente P, Muz B, Azab F, Luderer M, Azab AK. Molecularly targeted therapies in multiple myeloma. Leuk Res Treatment 2014; 2014: 976567.
2. Matsui W. Perspective: a model disease. Nature 2011; 480: S58.
3. Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008; 68: 190-197.
4. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23: 675-699.
5. Cosse JP, Michiels C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 2008; 8: 790-797.
6. Axelson H, Fredlund E, Ovenberger M, Landberg G, Pahlman S. Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 2005; 16: 554-563.
7. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007; 129: 465-472.
8. Azab AK, Hu J, Quang P, Azab F, Pitsillides C, Awwad R et al. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood 2012; 119: 5782-5794.
9. Colla S, Storti P, Donofrio G, Todoerti K, Bolzoni M, Lazzaretti M et al. Low bone marrow oxygen tension and hypoxia-inducible factor-1alpha overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells. Leukemia 2010; 24: 1967-1970.
10. Kawano Y, Kikukawa Y, Fujiwara S, Wada N, Okuno Y, Mitsuya H et al. Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells. Int J Oncol 2013; 43: 1809-1816.
11. Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008; 93: 431-438.
12. Abraham J, Salama NN, Azab AK. The role of P-glycoprotein in drug resistance in multiple myeloma. Leuk Lymphoma 2014; 1-8.
13. Reghunathan R, Bi C, Liu SC, Loong KT, Chung TH, Huang G et al. Clonogenic multiple myeloma cells have shared stemness signature assocuated with patient survival. Oncotarget 2013; 4: 1230-1240.
14. Chen HY, Ren XY, Wang WH, Zhang YX, Chen SF, Zhang B et al. Upregulated ROS production induced by the proteasome inhibitor MG-132 on XBP1 gene expression and cell apoptosis in Tca-8113 cells. Biomed Pharmacother 2014; 68: 709-713.
15. Vaux EC, Metzen E, Yeates KM, Ratcliffe PJ. Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 2001; 98: 296-302.
16. Srinivas V, Leshchinsky I, Sang N, King MP, Minchenko A, Caro J. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem 2001; 276: 21995-21998.
17. Fandrey J, Frede S, Jelkmann W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 1994; 303: 507-510.
18. Van Valckenborgh E, Matsui W, Agarwal P, Lub S, Dehui X, De Bruyne E et al. Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model. Leukemia 2012; 26: 1436-1439.
19. Muz B, de la Puente P, Azab F, Ghobrial IM, Azab AK. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenstrom's macroglobulinemia. Mol Cancer Res 2014; e-pub ahead of print September 2014; pii:molcanres.0150.2014.